Document:

Exhibit 10(i)

                           ACCENT COLOR SCIENCES, INC.

                       PREFERRED STOCK PURCHASE AGREEMENT

        This Preferred Stock Purchase  Agreement (the "Agreement") is made as of
the Closing Date (as hereinafter  defined) by and between Accent Color Sciences,
Inc., a Connecticut  corporation (the  "Company"),  with its principal office at
800 Connecticut  Boulevard,  East Hartford,  Connecticut  06018, and each of the
purchasers who are  signatories  hereto and any other  purchasers who are made a
party to this Agreement  pursuant to Section 1 (individually,  a "Purchaser" and
collectively, the "Purchasers").

                                    RECITALS

        The Company  has engaged  Pennsylvania  Merchant  Group (the  "Placement
Agent") as exclusive  agent of the Company in connection  with the placement and
sale  (the  "Offering")  of up to  40,000  shares  of  the  Company's  Series  C
Convertible  Preferred  Stock,  no par value per share  (the  "Series C Stock").
Shares of Series C Stock will be sold by the Company to  Purchasers  pursuant to
Regulation D under the  Securities  Act of 1933,  as amended  (the  "Act").  The
purchase  price of the  shares to be  offered  in the  Offering  (the  "Offering
Price") will be $100.00 per share.  The  Placement  Agent has  delivered to each
prospective purchaser a private placement  memorandum,  dated September 21, 1998
as supplemented by a first supplement to the private placement  memorandum dated
November 1, 1999  (collectively  the  "Placement  Memorandum"),  describing  the
Company's  business,   financial  and  operating  condition,  the  Offering  and
information  regarding risks to be evaluated when contemplating an investment in
the Company through the Offering.

                                    AGREEMENT

        In consideration of the mutual promises, representations, warranties and
conditions set forth in the Agreement, the Company and each Purchaser (severally
and not jointly) agree as follows:

        1.        PURCHASE AND SALE OF SHARES.

                  1.1     Issue of Shares.

                         (a) The Company has authorized the issuance and sale of
up to  40,000  shares  of its  Series C Stock  (the  "Shares")  pursuant  to the
provisions of this Agreement.

<PAGE>

                         (b) In reliance  upon the  Purchaser's  representations
and  warranties  contained  in  Section 4 hereof,  and  subject to the terms and
conditions set forth herein, the Company hereby agrees to sell to each Purchaser
the aggregate amount of Shares set forth below such Purchaser's signature on the
subscription  page bearing such Purchaser's  name, such Shares to be sold at the
Offering Price.

                         (c) In reliance upon the representations and warranties
of the Company  contained  herein,  and subject to the terms and  conditions set
forth herein,  each Purchaser  hereby agrees to purchase the amount of Shares as
determined  on the  subscription  page  bearing  such  Purchaser's  name  at the
Offering Price. Each Purchaser shall severally,  and not jointly,  be liable for
only the purchase of the amount of Shares that appears on the subscription  page
hereof that relates to such Purchaser.

                         (d) The Company's agreement with each of the Purchasers
is a separate  agreement and the sale of the Shares to each of the Purchasers is
a separate sale.

        2.        CLOSING DATE; DELIVERY.

                  2.1  Closing.  The  closing  of the sale and  purchase  of the
Shares  under  this  Agreement  (the  "Closing")  shall  consist of the sale and
purchase of the Shares and shall be held at the offices of the  Placement  Agent
at such time and date selected by the Placement Agent and the Company  occurring
on or before  December 1, 1999, or such later date to which the offering  period
is extended by the Company and the Placement Agent (the "Closing Date").

                  2.2  Delivery.  Within five (5) days  following  the  Closing,
subject to the terms and  conditions  hereof,  the Company shall deliver to each
Purchaser  stock  certificates,   registered  in  the  name  of  the  Purchaser,
representing the shares to be purchased by the Purchaser from the Company, dated
as of the Closing, against payment of the purchase price therefor in immediately
available funds by wire transfer or previously cleared check, unless other means
of payment shall have been agreed upon by the Purchaser and the Company.

        3.        REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

        The Company  hereby  represents and warrants to each Purchaser as of the
date hereof and as of the Closing Date as follows:

                  3.1   Organization.   The  Company  is  a  corporation,   duly
incorporated,   validly  and  legally   existing  and  under  the  laws  of  the
jurisdiction  of its  incorporation.  The  Company has all  requisite  power and
authority  to own or lease its  properties  and to conduct its business as it is
now being conducted. The Company holds all licenses and permits required for the
conduct of its business as it is now being  conducted other than those which, if
not  obtained,  would  not  have a  material  adverse  effect  on the  business,
financial  condition or results of  operations  of the  Company.  The Company is
qualified as a foreign or domestic corporation and is in good standing in all

<PAGE>

states where the conduct of its business or its ownership or leasing of property
requires  such  qualification,  except where the failure to so qualify would not
have a material adverse effect on the business,  financial  condition or results
of operations of the Company.  The Company has  previously  delivered a true and
complete copy of its Certificate of Incorporation  ("Certificate") and Bylaws to
the  Placement  Agent.  The Company  does not own any equity  securities  of, or
equity interest in, any corporation,  partnership,  limited liability company or
other person.

                  3.2  Capitalization.  The  authorized,  issued and outstanding
capital  stock of the  Company  on  September  21,  1999 is as set  forth in the
Placement  Memorandum under the heading "SUMMARY -- Capitalization."  All of the
issued  and  outstanding  shares of the  Company's  common  stock have been duly
authorized,  validly issued and are fully paid and nonassessable.  Except as set
forth on Schedule  3.2 hereof,  there are no  existing  subscriptions,  options,
stock option plans,  warrants,  calls,  commitments,  agreements,  conversion or
other rights of any character (contingent or otherwise) to purchase or otherwise
acquire from the Company at any time, or upon the happening of any stated event,
any shares of the capital stock of the Company.

                  3.3  Authority.  The  Company  has  all  requisite  power  and
authority to enter into this Agreement,  the  Registration  Rights Agreement (as
defined in Section 3.11 hereof) and the  Placement  Agent Warrant (as defined in
Section 6.6 hereof), and to consummate the transactions  contemplated hereby and
thereby.  The execution and delivery of this Agreement,  the Registration Rights
Agreement  and  the  Placement  Agent  Warrant,  and  the  consummation  of  the
transactions  contemplated hereby and thereby,  have been duly authorized by all
necessary  corporate  action  on the  part  of the  Company  or  will be so duly
authorized  by the Closing Date and,  upon their  execution  and delivery by the
Company,  such agreements will constitute  valid and binding  obligations of the
Company, enforceable against the Company in accordance with their terms, subject
to applicable  bankruptcy,  insolvency,  reorganization,  moratorium and similar
laws relating to or affecting  creditors'  rights and subject to general  equity
principles.

                  3.4     Securities Filings.

                         (a) The  Company  has  filed  with the  Securities  and
Exchange  Commission (the "SEC") the documents set forth as Exhibits A, B, C and
D of the Placement Memorandum (the "SEC Filings").  The SEC filings set forth as
Exhibits B, C and D are  amendments to the  Company's  Annual Report on Form 10K
for 1998, the Company's Quarterly Report on Form 10Q for the quarter ended March
31, 1999 and the Company's Quarterly Report for the quarter ended June 30, 1999,
respectively,  all as filed with the SEC in response to the  position of the SEC
that the  Company's  Series B  Convertible  Preferred  Stock  should  have  been
presented  in the  "mezzanine"  section of its balance  sheet rather than in the
equity  section of its  balance  sheet.  The  Company has filed with the SEC all
reports and all other filings  required to be filed with the SEC under the rules
and regulations of the SEC.

                         (b) Except as disclosed in Section 3.4(a)  hereof,  the
SEC  Filings  conformed  in all  material  respects to the  requirements  of the
Securities Exchange Act of

<PAGE>

1934, as amended (the "Exchange  Act"), and the rules and regulations of the SEC
thereunder  as of their  respective  filing  dates and did not contain an untrue
statement  of a material  fact or omit to state a material  fact  required to be
stated therein or necessary to make the statements  therein not misleading.  The
documents  or portions  thereof that were  incorporated  by reference in the SEC
Filings pursuant to the requirements of the Exchange Act, when such incorporated
documents or portions  were first filed with the SEC,  conformed in all material
respects with any applicable  requirements of the Exchange Act and the rules and
regulations of the SEC thereunder.

                         (c) Except as disclosed in Section 3.4(a)  hereof,  the
consolidated  financial  statements  of the Company  included in the SEC Filings
fairly presented in all material respects the financial  position and results of
operations  of the  Company  at their  respective  dates and for the  respective
periods to which they apply.  Such  financial  statements  have been prepared in
accordance with generally accepted accounting  principles  consistently  applied
throughout the periods involved except as stated therein.

                  3.5 Placement Memorandum.  The Placement Agent has advised the
Company  that it has  delivered  to each  prospective  purchaser  the  Placement
Memorandum,  which  describes  the Company's  business,  financial and operating
condition,  the Offering and  information  regarding  risks to be evaluated when
contemplating an investment in the Company through the Offering.

                         (a) The Placement Memorandum does not contain an untrue
statement  of a material  fact or omit to state a material  fact  required to be
stated therein or necessary to make the statements therein not misleading.

                         (b) Except as disclosed in Section 3.4(a)  hereof,  the
financial  statements of the Company included in the Placement Memorandum fairly
present  in  all  material  respects  the  financial  position  and  results  of
operations  of the  Company  at their  respective  dates and for the  respective
periods to which they apply.  Such  financial  statements  have been prepared in
accordance with generally accepted accounting  principles  consistently  applied
throughout the periods involved except as stated therein.

                  3.6 Issuance of the Shares.  The Shares,  when issued pursuant
to the terms of this Agreement, shall be duly and validly authorized and issued,
fully paid and nonassessable.

                  3.7 No Conflict with Law or Documents. The execution, delivery
and  consummation of this Agreement,  the  Registration  Rights  Agreement,  the
Placement  Agent Warrant and the  transactions  contemplated  hereby and thereby
will not (a) conflict with any  provisions of the  Certificate  or Bylaws of the
Company or (b) result in any violation of or default or loss of a benefit under,
or permit the  acceleration  of any  obligation  under (in each  case,  upon the
giving of notice, the passage of time, or both), any mortgage, indenture, lease,
agreement or other instrument,  permit,  franchise,  license,  judgment,  order,
decree, law, ordinance,  rule or regulation  applicable to the Company or any of
its properties.

<PAGE>

                  3.8 Consents,  Approvals and Private Offering.  Except for any
filings  required under federal and  applicable  state  securities  laws, all of
which shall have been made as of the Closing  Date to the extent  required as of
such time,  and the consent of each holder of the  Company's  Series B Preferred
Stock waiving its conversion  rights with respect to all shares issued  pursuant
to the terms of this Agreement,  which have been obtained, no consent, approval,
order or  authorization  of, or  registration,  declaration  or filing with, any
federal,  state,  local or foreign  governmental  authority  or other  person is
required to be made or obtained by the Company in connection  with the execution
and delivery of this Agreement, the Registration Rights Agreement, the Placement
Agent Warrant and the consummation of the transactions  contemplated  hereby and
thereby.

                  3.9 Absence of Certain Developments.  Since June 30, 1999, the
Company  has not (a)  incurred  or become  subject to any  material  liabilities
(absolute or contingent) except current  liabilities  incurred,  and liabilities
under contracts entered into, in the ordinary course of business consistent with
past practices; (b) mortgaged, pledged or subjected to any lien, charge or other
encumbrance  any of its  assets,  tangible or  intangible  (except for liens for
current taxes, assessments and governmental charges and levies which may be paid
without  penalty,  interest  or other  additional  charge,  or which  are  being
contested  in good faith by  appropriate  proceedings  and are not  material  in
amount or value in relation to the value of the associated property);  (c) sold,
assigned or  transferred  any of its assets or canceled any debts or obligations
except in the ordinary course of business  consistent  with past practices;  (d)
suffered any extraordinary  losses,  or waived any rights of substantial  value;
(e) except for a bridge  financing  closed  September 7, 1999 resulting in gross
proceeds to the Company of  $1,100,000,  entered into any  material  transaction
other than in the ordinary  course of business,  consistent with past practices;
or (f) otherwise had any change in its condition, financial or otherwise, except
as shown on or reflected in the consolidated  balance sheet as of June 30, 1999,
except for  changes in the  ordinary  course of  business  consistent  with past
practices.  Except as described in the SEC Filings,  the Company has not entered
into any agreement  since June 30, 1999 of the type that would be required under
the SEC's  rules and  regulations  to be filed as an exhibit to a Report on Form
10-K.

                  3.10   Litigation.   Except  as  described  in  the  Placement
Memorandum,  there are no actions, suits,  proceedings or investigations pending
against or affecting the Company or any Subsidiary  that in the aggregate  could
reasonably be anticipated to result in a material adverse effect on the Company.

                  3.11 Registration Rights. Each of the Shares shall be entitled
to the registration  rights provided by the Registration Rights Agreement in the
form  annexed  hereto  as  Exhibit  A.  If  the  Company  (a)  fails  to  file a
registration  statement,  as required by the Registration  Rights Agreement (the
"Registration Statement") with the SEC within 90 days of the Closing Date or (b)
fails to cause the  Registration  Statement to be declared  effective by the SEC
within 180 days of the Closing Date,  then the Company will issue  Purchaser for
no  additional  consideration  additional  shares of Series C Stock in an amount
equal to one share of Series C Stock  for each  twenty  shares of Series C Stock
purchased  hereunder  rounded  down  to  the  nearest  tenth  of a  share.  Such
additional shares of Series C stock shall be issued within 15 days

<PAGE>

of the Company's failure to satisfy (a) or (b) above. For example,  if Purchaser
purchased  100  shares of Series C Stock and the  Company  fails to (a) file the
Registration  Statement  with the SEC within 90 days of the Closing  Date or (b)
fails to cause the  Registration  Statement to be declared  effective by the SEC
within  180  days of the  Closing  Date,  then it will  issue  the  Purchaser  5
additional shares of Series C Stock in accordance with this paragraph.

        4.   REPRESENTATIONS, WARRANTIES AND CERTAIN COVENANTS OF THE PURCHASER.

                  Each  Purchaser   hereby   represents  and  warrants  to,  and
covenants with, the Company as follows:

                  4.1  Legal  Power.  Purchaser  has  the  requisite  corporate,
partnership,  trust or fiduciary  power, as appropriate,  and is authorized,  if
Purchaser is a corporation,  partnership or trust, to enter into this Agreement,
to purchase the Shares  hereunder,  and to carry out and perform its obligations
under the terms of this Agreement and the Registration Rights Agreement.

                  4.2 Due Execution. Each of this Agreement and the Registration
Rights  Agreement  has been duly  authorized,  if  Purchaser  is a  corporation,
partnership,  trust or fiduciary,  executed and delivered by Purchaser and, upon
due execution and delivery by the Company,  this Agreement and the  Registration
Rights Agreement will be valid and binding agreements of Purchaser,  enforceable
against  Purchaser  in  accordance  with  their  terms,  subject  to  applicable
bankruptcy, insolvency, reorganization,  moratorium and similar laws relating to
or affecting creditors' rights and subject to general equity principles.

                  4.3     Investment Representations.

                  4.3.1  Purchaser is acquiring  the Shares for its own account,
not as nominee or agent,  for investment and not with a view to or for resale in
connection with any  distribution or public offering  thereof within the meaning
of the Act,  except  pursuant to an effective  registration  statement under the
Act.

                  4.3.2 Purchaser  understands that (i) the Shares have not been
registered under the Act by reason of a specific  exemption  therefrom,  and may
not be  transferred  or resold  except  pursuant  to an  effective  registration
statement or exemption from registration and (ii) each certificate  representing
the Shares will be endorsed with legends in substantially the following form:

                  A) THE SECURITIES  REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
        UNDER THE SECURITIES  ACT OF 1933, AS AMENDED (THE "ACT"),  OR UNDER THE
        SECURITIES  LAWS  OF  ANY  STATE.   THESE   SECURITIES  ARE  SUBJECT  TO
        RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR
        RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES

<PAGE>

        LAWS  PURSUANT TO  REGISTRATION  OR EXEMPTION  THEREFROM.  THE ISSUER OF
        THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE
        SATISFACTORY  TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED  TRANSFER OR
        RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES
        LAWS;

                    B) Any legend  required to be placed  thereon by  applicable
        federal or state securities laws;

and (iii) the Company  will  instruct  any  transfer  agent not to register  the
transfer of any of the Shares unless the  conditions  specified in the foregoing
legend are satisfied.

                  4.3.3  Purchaser  has  received  and  reviewed  the  Placement
Memorandum.  In addition,  Purchaser has been  furnished with such materials and
has been given access to such  information  relating to the Company as it or its
qualified  representative has requested and has been afforded the opportunity to
ask questions  regarding the Company and the Shares,  all as Purchaser has found
necessary to make an informed investment decision.

                  4.3.4  Purchaser is an  "accredited  investor" as such term is
defined in Rule 501 under the Act and was not formed for the specific purpose of
acquiring the Shares.

                  4.3.5  Purchaser  is a  resident  of,  and all  communications
regarding  Purchaser's  purchase  of the Shares were sent to  Purchaser  in, the
state of Purchaser's residence shown on the subscription page attached hereto.

        5.        COVENANTS OF THE COMPANY.

                  5.1     Information.

                  So long as the  Company is subject to the  periodic  reporting
requirements  of the Exchange  Act, the Company  shall deliver to each holder of
Shares all annual,  quarterly  or other  reports to the extent such  reports are
furnished  to the  Company's  public  security  holders.  In the event  that the
Company  is not so  subject,  until the fifth  anniversary  of the  Closing  the
Company  shall  promptly  furnish  to  each  holder  of  Shares  (i) as  soon as
available,  and in any event within 90 days after the end of each fiscal year of
the Company,  a consolidated  balance sheet of the Company and its  consolidated
subsidiaries,  if any,  as of the  end of  such  fiscal  year  and  the  related
consolidated statements of income,  stockholders' equity and cash flows for such
fiscal year,  setting forth in each case in comparative form the figures for the
previous  fiscal  year,  all  prepared in  accordance  with  generally  accepted
accounting   principles  and  reported  on  by  independent   certified   public
accountants of recognized national standing; and (ii) as soon as available,  and
in any event  within 45 days  after  the end of each of the first  three  fiscal
quarters of each fiscal year of the Company, a consolidated balance sheet of the
Company and its consolidated subsidiaries, if any, as of the end of such quarter
and the  related  consolidated  statements  of income and  stockholder's  equity
(together with any other quarterly  financial  statements  being prepared by the
Company  at such  time),  setting  forth in each  case in  comparative  form the
figures  for the  corresponding  quarter  and the  corresponding  portion of the
Company's  previous  fiscal  year,  all  certified  (subject to normal  year-end
adjustments)  as to  fairness  of  presentation  and  consistency  by the  chief
financial or accounting officer of the Company.

<PAGE>

               5.2 Use of  Proceeds.  The Company  will use the  proceeds of the
Offering in a manner in accordance with the Placement Memorandum.

          6.  REPRESENTATIONS  OF  PLACEMENT  AGENT;  COMPENSATION  OF PLACEMENT
AGENT.  The Company has authorized  the Placement  Agent to conduct the Offering
under  Regulation D of the Act, and the Placement  Agent  represents  and agrees
with the Company as follows:

                  6.1 Sales to Accredited  Investors.  The  Placement  Agent has
made and will  only  make  offers  and  sales of the  Shares  to  Purchasers  it
reasonably believes to be "accredited investors" as that term is defined in Rule
501(a) under the Act.

                  6.2 Regulation D Compliance.  The Placement Agent has made and
will make offers and sales of Shares in  compliance  with Rule 506 and the other
applicable provisions of Regulation D, to the extent applicable to the Placement
Agent,  and the Placement Agent has not and will not offer to sell the Shares by
any form of general  solicitation or general  advertising  that is prohibited by
Rule 502(c) under the Act.

                  6.3  Compliance  Generally.  The Placement  Agent has and will
observe all securities laws and regulations applicable to it in any jurisdiction
in which it has or may offer,  sell or deliver Shares and it will not,  directly
or  indirectly,  offer,  sell or deliver  Shares or  distribute  or publish  any
prospectus,  circular,  advertisement or other offering  material in relation to
the Shares in or from any state in the United States or country or  jurisdiction
except under  circumstances  that will result in compliance with applicable laws
and regulations.

                  6.4  Sales  Commissions.  In  consideration  of the  Placement
Agent's services hereunder, the Company shall pay the Placement Agent in cash on
the Closing Date a commission of seven percent  (7.0%) of the Offering  Price of
each Share sold at such Closing (the "Placement Fee").

                  6.5 Placement  Agent Expenses.  Upon the Closing,  the Company
agrees  to  reimburse  the  Placement  Agent  for  its  reasonable,   documented
out-of-pocket  expenses incurred in connection with the Offering,  including the
reasonable fees and expenses of the Placement  Agent's counsel,  up to a maximum
of $20,000.

                  6.6 Placement Agent Warrant. At the Closing, the Company shall
sell to the Placement  Agent warrants to purchase 25,000 shares of the Company's
common  stock for each  $1,000,000  of gross  proceeds to the  Company  from the
Offering,  prorated for any amount less than $1,000,000  (the  "Placement  Agent
Warrant"),  at a purchase price of $.001 per share of the Company's common stock
underlying  the Placement  Agent Warrant (the "Warrant  Shares").  The Placement
Agent Warrant shall be exercisable  at any time before the fifth  anniversary of
the Closing at an exercise price per share of $.40. The Placement  Agent Warrant
shall be in a form satisfactory to the Company and the Placement Agent.

                  6.7 Possible  Participation  by Affiliates of Placement Agent.
Affiliates of the Placement  Agent may purchase  Series C Stock in the Offering.
Purchases  by such  affiliates  may be  counted  toward any  applicable  minimum
proceeds requirement,  but no such individual Placement Agent affiliate purchase
shall consist of more than 10% of such

<PAGE>

minimum.  If such minimum is exceeded,  no individual  Placement Agent affiliate
purchase  beyond that minimum shall exceed 10% of the Series C Stock sold in the
Offering and all Placement Agent affiliate  purchases  beyond such minimum shall
not in the aggregate exceed 20% of the Series C Stock sold in the Offering.

        7.        CONDITIONS TO CLOSING.

                  7.1  Conditions  to   Obligations   of  the  Purchaser.   Each
Purchaser's  obligation  to purchase the Shares at the Closing is subject to the
fulfillment, at or prior to such Closing, of all of the following conditions:

                    (a)  Representations  and  Warranties  True;  Performance of
Obligations. The representations and warranties made by the Company in Section 3
hereof  shall be true and correct in all  material  respects at the Closing with
the same  force  and  effect  as if they had been  made on and as of said  date.
Except  as  described  in or  contemplated  by  the  Placement  Memorandum,  the
business,  assets,  financial condition and results of operations of the Company
shall not have been adversely affected in any material way prior to the Closing.
The Company shall have performed in all material respects all obligations herein
required to be performed by it on or prior to the Closing.

                    (b)  Proceedings  and  Documents.  All  corporate  and other
proceedings  in connection  with the  transactions  contemplated  at the Closing
hereby and all documents and instruments  incident to such transactions shall be
reasonably satisfactory in substance and form to the Purchaser.

                    (c)  Qualifications,  Legal Investment.  All authorizations,
approvals,  or permits, if any, of any governmental authority or regulatory body
of the United  States or of any state that are required in  connection  with the
lawful sale and  issuance of the Shares  pursuant to this  Agreement  shall have
been duly  obtained and shall be effective on and as of the Closing Date. At the
time of the  Closing,  the sale and  issuance  of the  Shares  shall be  legally
permitted by all laws and regulations to which the Purchaser and the Company are
subject.

                    (d) Registration  Rights  Agreement.  The Company shall have
entered into the Registration Rights Agreement.

                    (e)  Legal  Opinion.  Counsel  to  the  Company  shall  have
provided  a  legal  opinion  to  the  Purchasers  reasonably  acceptable  to the
Placement Agent.

                  7.2 Conditions to  Obligations  of the Company.  The Company's
obligation  to issue  and sell the  Shares  at the  Closing  is  subject  to the
fulfillment to the Company's  satisfaction,  on or prior to the Closing,  of the
following conditions:

                    (a) Representations and Warranties True. The representations
and  warranties  in Section 4 hereof  made by each  Purchaser  shall be true and
correct at the  Closing  with the same force and effect as if they had been made
on and as of the Closing.

                    (b)  Performance of  Obligations.  Each Purchaser shall have
performed  and  complied  in all  material  respects  with  all  agreements  and
conditions herein

<PAGE>

required to be performed or complied with by them on or before the Closing Date,
and each Purchaser shall have delivered payment to the Company in respect of its
purchase of Shares.

                    (c)  Qualifications,  Legal Investment.  All authorizations,
approvals,  or permits, if any, of any governmental authority or regulatory body
of the United  States or of any state that are required in  connection  with the
lawful sale and  issuance of the Shares  pursuant to this  Agreement  shall have
been duly  obtained and shall be effective on and as of the Closing Date. At the
time of the  Closing,  the sale and  issuance  of the  Shares  shall be  legally
permitted by all laws and  regulations  to which each  Purchaser and the Company
are subject.

        8.        MISCELLANEOUS.

                    8.1 Governing Law. This  Agreement  shall be governed by and
construed  under  the  laws  of  Connecticut  without  regard  to any  otherwise
applicable principles of conflicts of laws.

                  8.2 Survival.  The  representations and warranties made by the
parties in this Agreement  shall survive the  consummation  of the  transactions
herein  contemplated  until the  expiration of the statute of  limitations  with
respect to claims arising under Section 10(b) of the Securities  Exchange Act of
1934, as amended, with respect to the purchase of Shares hereunder.

                  8.3  Successors  and Assigns.  Except as  otherwise  expressly
provided  herein,  the  provisions  hereof shall inure to the benefit of, and be
binding upon, the successors,  assigns,  heirs,  executors and administrators of
the parties hereto.

                  8.4 Entire  Agreement.  This Agreement and the Exhibits hereto
and thereto,  and the other  documents  delivered  pursuant  hereto and thereto,
constitute  the full and entire  understanding  and agreement  among the parties
with regard to the subjects  hereof and no party shall be liable or bound to any
other  party in any  manner by any  representations,  warranties,  covenants  or
agreements  except as specifically set forth herein or therein.  Nothing in this
Agreement,  express or implied, is intended to confer upon any party, other than
the parties  hereto and their  respective  successors  and assigns,  any rights,
remedies,  obligations,  or  liabilities  under or by reason of this  Agreement,
except as expressly provided herein.

                  8.5  Severability.  In the event  that any  provision  of this
Agreement shall be invalid,  illegal or  unenforceable,  it shall, to the extent
practicable,  be modified so as to make it valid,  legal and  enforceable and to
retain as nearly as  practicable  the intent of the parties,  and the  validity,
legality, and enforceability of the remaining provisions shall not in any way be
affected or impaired thereby. To the extent permitted by law, the parties hereto
waive the benefit of any  provision  of law that  renders any  provision of this
Agreement invalid or unenforceable in any respect.

                  8.6 Joinder.  By execution of this  Agreement,  the  Placement
Agent joins this Agreement for purposes of (i) making the representations of the
Placement Agent set forth in Section 6 hereof and (ii) receiving the benefits of
the Company's covenants in such Section 6.

<PAGE>

                  8.7 Amendment and Waiver. Except as otherwise provided herein,
any term of this  Agreement  may be amended,  and the  observance of any term of
this  Agreement  may be waived  (either  generally or in a particular  instance,
either retroactively or prospectively, and either for a specified period of time
or indefinitely), with the written consent of the Company and the Purchaser. Any
amendment or waiver  effected in  accordance  with this section shall be binding
upon  each  future  holder  of  any  security  purchased  under  this  Agreement
(including  securities  into which such  securities have been converted) and the
Company.

                  8.8 Notices. All notices and other communications  required or
permitted  hereunder shall be in writing and shall be deemed  effectively  given
upon personal delivery, on the first business day following mailing by overnight
courier,  or on the fifth day following mailing by registered or certified mail,
return  receipt  requested,  postage  prepaid,  addressed to the Company and the
Purchaser at the respective addresses included herein.

                  8.9 Fees and Expenses.  Except as otherwise  provided  herein,
the  Company and the  Purchasers  shall bear their own  expenses  and legal fees
incurred  on its behalf  with  respect to this  Agreement  and the  transactions
contemplated  hereby.  Purchasers  acknowledge  that the  Placement  Agent  will
receive a commission  equal to seven percent (7%) of the Offering  Price of each
Share  sold in the  Offering  and  will be  entitled  to  purchase  for  nominal
consideration the Placement Agent Warrant.

                  8.10 Titles and  Subtitles.  The titles of the  paragraphs and
subparagraphs  of this  Agreement are for  convenience of reference only and are
not to be considered in construing this Agreement.

                  8.11  Counterparts.  This  Agreement  may be  executed  in any
number of  counterparts,  each of which shall be deemed an original,  but all of
which together shall constitute one instrument.

                  8.12 No Waiver.  No waiver by any party to this  Agreement  of
any one or more defaults by any other party or parties in the performance of any
of the provisions hereof shall operate or be construed as a waiver of any future
default or defaults,  whether of a like or different nature. Except as expressly
provided herein,  no failure or delay on the part of any party in exercising any
right,  power or remedy  hereunder shall operate as a waiver thereof,  nor shall
any single or partial  exercise of any such right,  power or remedy preclude any
other or further exercise  thereof or the exercise of any other right,  power or
remedy.

                            [SIGNATURE PAGE FOLLOWS]

<PAGE>

                           ACCENT COLOR SCIENCES, INC.

                       PREFERRED STOCK PURCHASE AGREEMENT

                        AND REGISTRATION RIGHTS AGREEMENT

                                 SIGNATURE PAGE

Please  complete  two copies of the  Signature  Page and return  both copies to:
Pennsylvania Merchant Group, Four Falls Corporate Center, West Conshohocken,  PA
19428-2961, Attention: Mary E. Bowler.

---------------------------------------            -----------------------------
Purchaser's Name - Please Print                    Nominee Name (if appropriate)

---------------------------------------            -----------------------------
Social Security Number/Tax I.D. Number             Telephone Number

                                                   -----------------------------
                                                   Fax Number

----------------------------------------           -----------------------------
Address                                            City, State and Zip Code

----------------------------------------           -----------------------------
Signature                                          Date

--------------------------------------------------------------------------------

Number of Shares to be Purchased    Price Per Share     Aggregate Purchase Price

----------------------------------------    X       =      $--------------------

FUNDS  SHOULD BE WIRED  TO:  SUMMIT  BANK/Trust,  Attention:  Shernetta  Harris,
Hackensack, NJ ABA #021202162 GL A/C 477-02. For credit to the Account of Accent
Color Sciences, Inc. Trust Account #2970056498.

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

AGREED TO AND ACCEPTED:

PENNSYLVANIA MERCHANT GROUP

By:-------------------------------------         Date:--------------------------
     Mary E. Bowler
     Vice President - Administration

ACCENT COLOR SCIENCES, INC.

                                              By:-------------------------------
                                                 Date:--------------------------Exhibit 10(ii)

         RESOLVED:   That  Article   Fourth  of  the  Restated   Certificate  of
         Incorporation of the corporation, as amended, be amended to include the
         rights and  designation of the Series C Convertible  Preferred Stock by
         adding to Article Fourth thereof a new subsection F as follows:

F.       SERIES C PREFERRED STOCK

         1. Designation. There is hereby created a series of the Preferred Stock
consisting of 50,000 shares having the designation,  voting powers, preferences,
relative,   participating,   optional   and  other   special   rights   and  the
qualifications,  limitations and  restrictions  thereof as are set forth in this
Paragraph F. This series is designated  "Series C Convertible  Preferred  Stock"
(hereinafter called "Series C Stock").

         2.       Cash Dividend.

                  (a) The record holders of the  outstanding  shares of Series C
Stock  ("Series C  Holders")  shall be entitled  to receive  noncumulative  cash
dividends when and as declared by the Board of Directors,  provided that no such
dividend  shall be  declared  unless an  equivalent,  ratable  dividend  is also
declared with respect to the outstanding shares of Series B Stock.

                  (b) In addition to any dividends  declared in accordance  with
the preceding  subparagraph (a), the holders of Series C Stock shall be entitled
to receive  dividends at the rate of 8% per annum of the initial  purchase price
of $100 per share,  cumulative  from the issuance date, but not to exceed 47% in
the  aggregate,  provided  that  such  dividends  shall be  payable  only upon a
Liquidation  Event (as  defined  herein),  and  provided  further  that any such
dividend  payment shall be coupled with an equivalent,  ratable  dividend to the
holders of Series B Stock  calculated  upon the  initial  purchase  price of the
Series B Stock of $1,000  per  share.  Payment  of  dividends  pursuant  to this
subparagraph  (b) shall be made in full  prior to the  payment of  dividends  on
Common Stock.

                  (c) Upon the  payment  or  setting  apart for  payment  of any
dividends upon the outstanding  shares of Series C Stock and Series B Stock, the
Board of Directors may declare and pay dividends  upon the Common Stock up to an
amount  with  respect to each share of Common  Stock equal to the amount paid or
set aside for payment  with respect to each share of Series C Stock and Series B
Stock divided,  in each case, by the number of shares of Common Stock into which
each such share of Series C Stock or Series B Stock shall then be convertible.

          3. Redemption.  The Series C Stock may not be redeemed, in whole or in
part

         4.       Liquidation.

                  (a) In the event of a  Liquidation  Event,  any amount paid or
payable to the Series C Holders shall rank, in right of payment, pari passu with

<PAGE>

any and all  amounts  then  payable by reason of such  Liquidation  Event to the
holders of Series B Stock and any declared but unpaid  dividends on the Series B
Stock and senior to all other classes of stock.

                  (b) Subject to the preceding subparagraph (a), in the event of
any  Liquidation  Event,  the Series C Holders  shall be  entitled to be paid an
amount  equal to One  Hundred  Dollars  ($100.00)  per share plus all  dividends
thereon accrued and remaining  unpaid up to the date of such  Liquidation  Event
whether or not at such times the  corporation  shall have surplus  available for
the payment of dividends.

                  (c) In the  event  of any  Liquidation  Event,  the  Series  C
Holders  shall not  participate  further  in any  liquidating  distributions  to
holders  of Common  Stock,  but shall be given not less than 20  business  days'
prior  written  notice of any  Liquidation  Event in order to decide  whether to
convert their shares prior to the Liquidation Event.

                  (d) A merger, consolidation,  dissolution,  winding up or sale
of all or substantially all of the assets of the Corporation,  whether voluntary
or involuntary,  shall be deemed to be a liquidation event ("Liquidation Event")
unless (a) in the case of a merger,  the Corporation is the surviving  entity or
(b) the  holders  of at least 75% of the  combined  Series C Stock and  Series B
Stock determine that such action should not be deemed a Liquidation Event.

         5.       Conversion.

                  (a) Right to Convert  and  Conversion  Rate.  At the option of
each holder of Series C Stock, such holder's holdings of Series C Stock shall be
convertible  into  shares of Common  Stock at any time and from time to time and
cash in lieu of fractional shares upon the following terms and conditions:

                         (i) Each share of Series C Stock  shall be  convertible
from and after the date of its issuance at the office of any Transfer  Agent for
the Series C Stock (or such other place as may be designated by the corporation)
into fully paid and non-assessable  shares of Common Stock (as such Common Stock
shall  then  be   constituted)   into  such  whole  number  of  fully  paid  and
nonassessable  shares of Common Stock as equals $100  divided by the  Conversion
Price (as last  adjusted  and then in  effect).  The  "Conversion  Price"  shall
initially be equal to forty cents ($.40); provided however, that such Conversion
Price shall be subject to  adjustment  to the extent  provided in subpart (b) of
this subparagraph 5.

                         (ii) In order to convert  shares of Series C Stock into
Common Stock, the holder thereof shall surrender the certificate or certificates
for Series C Stock,  duly endorsed to the corporation or in blank, at the office
of any  Transfer  Agent for the  Series C Stock (or such  other  place as may be
designated by the corporation), and shall give written notice to the corporation
at said  office  that he elects to convert  the same and shall  state in writing
therein the name or names in which he wishes the certificate or certificates for
Common  Stock  to be  issued.  The  corporation  will,  as soon  as  practicable
thereafter,  deliver  at said

<PAGE>

office to such holder of shares of the Series C Stock such  holder's  nominee or
nominees,  a certificate or certificates for the number of full shares of Common
Stock to which such holder shall be entitled as aforesaid.  Shares of the Series
C Stock shall be deemed to have been  converted as of the date of the  surrender
of such  certificate or certificates  for conversion as provided above,  and the
person or persons  entitled  to  receive  the Common  Stock  issuable  upon such
conversion  shall be treated for all purposes as the record holder or holders of
such Common Stock on such date.

               (b)  Conversion  Adjustment   Provisions.   The  conversion  rate
provided in subpart (a) (i) above shall be subject to  adjustment  to the extent
provided below:

                              (i)    Stock    Dividends,     Subdivisions    and
                    Combinations. In the event the corporation shall

                              (x) pay a  dividend  of  Common  Stock,  or of any
                    capital  stock   convertible   into  Common  Stock,  on  its
                    outstanding Common Stock;

                              (y) subdivide its outstanding  Common Stock into a
                    larger number of shares of Common Stock by  reclassification
                    or otherwise; or

                              (z) combine its  outstanding  Common  Stock into a
                    smaller number of shares of Common Stock by reclassification
                    or otherwise.

                    the  conversion  rate in effect  immediately  prior  thereto
                    shall be proportionately  adjusted so that the holder of any
                    Series C Stock  thereafter  surrendered for conversion shall
                    be entitled to receive the number of shares of Common  Stock
                    (and,  in the case of a dividend  payable  in capital  stock
                    convertible  into Common Stock, the number of shares of such
                    capital  stock)  which such holder  would have owned or have
                    been  entitled to receive  after the happening of any of the
                    events   described  above  had  such  Series  C  Stock  been
                    converted  immediately prior to the happening of such event.
                    Such  adjustment  shall be made  whenever  any of the events
                    described above shall occur. In the case of a dividend,  any
                    such adjustment  shall be made as of the record date thereof
                    and in the case of a subdivision  or  combination,  any such
                    adjustment shall be made as of the effective date thereof.

                              (ii)  Minimum   Adjustment.   Notwithstanding  the
                    provisions  of (i) of this subpart (b), no adjustment in the
                    conversion  rate shall be required  unless  such  adjustment
                    would require an increase or decrease of at least 2% of such
                    rate; provided, however, that any such adjustments which
<PAGE>

                    are not  required  to be made shall be carried  forward  and
                    taken  into  account  in  any  subsequent  adjustment.   All
                    calculations  required by any  provision of this subpart (b)
                    shall  be  made  to  the  nearest  cent  or to  the  nearest
                    one-hundredth of a share, as the case may be.

                              (iii) Notice of Adjustment  of  Conversion  Price.
                    Whenever the Conversion  Price shall be adjusted as provided
                    in this  subsection  (b), the  corporation  shall  forthwith
                    file,  at the office of the transfer  agent for the Series C
                    Stock or at such  other  place as may be  designated  by the
                    corporation,   a  statement,   signed  by  its   independent
                    certified public accountants or its Chief Financial Officer,
                    showing in detail the facts  requiring  such  adjustment and
                    the  Conversion  Price  that  shall be in effect  after such
                    adjustment.  The corporation shall also cause a copy of such
                    statement to be sent by first class,  certified mail, return
                    receipt requested, postage prepaid, to each holder of shares
                    of Preferred Stock at such holder's address appearing on the
                    corporation's records.

                  (c) Fractional  Shares. No fraction of a share of Common Stock
shall be issued  upon any  conversion  of Series C Stock but,  in lieu  thereof,
there  shall be paid an amount in cash equal to the same  fraction of the market
value of a full share of Common Stock.  For such purpose,  the market value of a
share of Common  Stock shall be the market value at the close of the most recent
trading day prior to the date as of which the  determination is made;  provided,
however,  that if the  Common  Stock is not  traded  in such  manner  that  such
valuation  referred to herein is available,  market value shall be determined in
good faith by the Board of Directors of the corporation.

                  (d) Reservation of Common Stock. The corporation  shall at all
times reserve and keep available out of its authorized but unissued Common Stock
solely for the purposes of effecting the  conversion of the shares of the Series
C Stock,  the full number of shares of Common  Stock then  deliverable  upon the
conversion of all shares of Series C Stock at the time outstanding.

          6. Voting on  Amendments  to the  Certificate  of  Incorporation  as a
Class.

                    (a) The  Series C  Holders  shall be  entitled  to vote as a
separate  voting  group  on  any  proposed   amendments  to  the   corporation's
Certificate  of   Incorporation   (including  any  applicable   Certificates  of
Designation), whether or not such voting rights are granted by Section 33-798 of
the  Connecticut  Business  Corporation  Act  or a  successor  thereto,  if  the
amendment would:

                              (i) Increase or decrease the  aggregate  number of
                    authorized shares of the Series C Stock;

<PAGE>

                              (ii) Effect an exchange or reclassification of all
                    or part of the shares of the  Series C Stock into  shares of
                    another class;

                              (iii) Effect an exchange or  reclassification,  or
                    create the right of  exchange,  of all or part of the shares
                    of another class into shares of the Series C Stock;

                              (iv) Change the designation,  rights,  preferences
                    or  limitations of all or part of the shares of the Series C
                    Stock;

                              (v) Change the shares of all or part of the Series
                    C Stock into a different number of shares of the same class;

                              (vi) Create a new class of shares having rights or
                    preferences  with respect to distributions or to dissolution
                    that  are  prior,  superior  or  substantially  equal to the
                    shares of the Series C Stock;

                              (vii)  Increase the rights,  preferences or number
                    of authorized  shares of any class that, after giving effect
                    to the amendment, have rights or preferences with respect to
                    distributions or to dissolution that are prior,  superior or
                    substantially equal to the shares of the Series C Stock; or

                              (viii)  Cancel  or  otherwise   affect  rights  to
                    distributions or dividends that have accumulated but not yet
                    been  declared  on all or part of the shares of the Series C
                    Stock.

                    (b) If a proposed amendment that entitles the Series C Stock
and one or more other series of shares to vote as separate  voting  groups under
this section  would affect the Series C Stock and such one or more series in the
same or a  substantially  similar  way, the shares of all the series so affected
must vote together as a single voting group on the proposed amendment.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}]]